NEW YORK, Dec. 24, 2020 /PRNewswire/ -- Anchiano Therapeutics Ltd. (NASDAQ: ANCN) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of ANCN with Chemomab Ltd. ANCN shareholders will only receive 10% of the combined...
from PR Newswire: https://ift.tt/2KPJ0O6
No comments:
Post a Comment